$316 Thousand is the total value of Krensavage Asset Management, LLC's 12 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTHR | Buy | UNITED THERAPEUTICS CORP | $44,749 | -1.1% | 202,715 | +0.3% | 14.18% | +3.1% |
| CAH | Buy | CARDINAL HEALTH INC | $33,451 | +25.4% | 353,714 | +0.1% | 10.60% | +30.8% |
| TARO | Buy | TARO PHARMACEUTICAL INDUS | $24,392 | +56.2% | 643,080 | +0.2% | 7.73% | +63.0% |
| Buy | EMBECTA CORP | $23,129 | -22.6% | 1,070,810 | +0.8% | 7.33% | -19.2% | |
| ENTA | Buy | ENANTA PHARMACEUTICALS INC | $14,715 | -39.7% | 687,613 | +14.0% | 4.66% | -37.1% |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $2,392 | -2.6% | 362,951 | +0.4% | 0.76% | +1.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP | 39 | Q2 2024 | 18.1% |
| Enanta Pharmceuticals Inc | 38 | Q2 2024 | 16.7% |
| INVACARE CORP | 28 | Q3 2021 | 5.8% |
| RTI SURGICAL INC | 23 | Q2 2020 | 7.9% |
| BIOGEN INC | 22 | Q2 2024 | 16.0% |
| MCKESSON CORP | 20 | Q3 2022 | 16.3% |
| REGENERON PHARMACEUTICALS | 19 | Q2 2024 | 16.1% |
| ALKERMES PLC | 19 | Q2 2024 | 14.1% |
| TARO PHARMACEUTICAL INDUS | 19 | Q2 2024 | 14.0% |
| MERCK & CO. INC. | 18 | Q1 2019 | 11.1% |
View Krensavage Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SURGALIGN HOLDINGS, INC. | February 19, 2021 | 5,380,449 | 6.6% |
| RTI SURGICAL, INC. | February 14, 2019 | 3,852,567 | 6.1% |
| Aviragen Therapeutics, Inc. | February 15, 2018 | 2,292,058 | 5.9% |
| ENANTA PHARMACEUTICALS INC | February 15, 2017 | 883,902 | 4.6% |
| Biota Pharmaceuticals, Inc. | February 17, 2016 | 2,267,655 | 5.9% |
View Krensavage Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-15 |
| 13F-HR | 2024-05-15 |
| SCHEDULE 13G | 2024-02-27 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
View Krensavage Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.